Previous close | 2.5400 |
Open | 2.5800 |
Bid | 2.5200 |
Ask | 2.5700 |
Strike | 90.00 |
Expiry date | 2023-11-17 |
Day's range | 2.5800 - 2.8300 |
Contract range | N/A |
Volume | |
Open interest | 1.01k |
Novavax gets green light from FDA, awaits CDC recommendation for booster COVID doses.
The Serum Institute of India has received a recommendation from WHO for malaria doses using a Novavax adjuvant.
(Bloomberg) -- Novavax Inc.’s updated version of its Covid-19 shot gained US regulators’ authorization for emergency use amid a rocky rollout of competitors’ offerings.Most Read from BloombergKey Taiwan Tech Firms Helping Huawei With China Chip PlantsWall Street Fear Gauge Ratchets Up After Jobs Data: Markets WrapKevin McCarthy Ousted as US House Speaker by Republican DissidentsWhy a US Recession Is Still Likely — and Coming SoonAirbnb Is Fundamentally Broken, Its CEO Says. He Plans to Fix It.Th